Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994661 | 12699466 | 1 | I | 20160815 | 20160830 | 20160830 | EXP | NL-RICONPHARMA LLC-2016RIC00005 | RICONPHARMA | KOOP AMC, VROEMEN JPAM, SCHREINEMAKERS JMJ. INTRAMUSCULAR CALCIFICATIONS AFTER QUININE INJECTIONS. ANN TROP MED PUBLIC HEALTH (DOI: 10.4103/1755-6783.184812). 2016;9(4):263-265 | 45.00 | YR | F | Y | 0.00000 | 20160829 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994661 | 12699466 | 1 | PS | QUININE SULFATE. | QUININE SULFATE | 1 | Intramuscular | 10 MG/KG, 3X/DAY FOR SEVERAL DAYS IN BOTH UPPER LEGS | 204372 | 10 | MG/KG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126994661 | 12699466 | 1 | Malaria |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126994661 | 12699466 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126994661 | 12699466 | Pseudocyst |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |